- A polyvalent vaccine for high-risk prostate patients: "are more antigens better?". Slovin, S.F., Ragupathi, G., Fernandez, C., Diani, M., Jefferson, M.P., Wilton, A., Kelly, W.K., Morris, M., Solit, D., Clausen, H., Livingston, P., Scher, H.I. Cancer Immunol. Immunother. (2007)